175 related articles for article (PubMed ID: 2239570)
21. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
[TBL] [Abstract][Full Text] [Related]
22. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
Washida H; Sakagami H; Iwase Y; Sasaki S
Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
[TBL] [Abstract][Full Text] [Related]
23. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
[No Abstract] [Full Text] [Related]
24. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of sultamicillin in the treatment of urinary tract infections].
Fukatsu H; Noonmura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Yamada Y; Segawa A
Hinyokika Kiyo; 1990 Jul; 36(7):861-7. PubMed ID: 2239586
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
[TBL] [Abstract][Full Text] [Related]
27. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
[TBL] [Abstract][Full Text] [Related]
28. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Loba J; Markuszewski L
Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
[TBL] [Abstract][Full Text] [Related]
29. [Clinical trial of HAPA-B in complicated urinary tract infections].
Kamiryo Y; Kato M; Sanefuji T; Hirao H
Hinyokika Kiyo; 1986 Sep; 32(9):1379-85. PubMed ID: 3101447
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of cefmetazole in urological infections].
Mitsuya H; Naide Y; Ohtaguro K; Segawa A
Hinyokika Kiyo; 1984 Jan; 30(1):87-95. PubMed ID: 6587764
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
Takaha M; Ichikawa Y; Sagawa S; Sonoda T; Nakamura T; Kotake T; Miki T; Yano H; Itatani H; Shin T
Hinyokika Kiyo; 1984 Oct; 30(10):1519-29. PubMed ID: 6098179
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of cefotetan in complicated urinary tract infections].
Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
[TBL] [Abstract][Full Text] [Related]
34. [A clinical evaluation of CS-807 in patients with urinary tract infections].
Nakajima K; Oshinoya Y; Uchibayashi T; Ohkawa M; Hisazumi H
Hinyokika Kiyo; 1988 Aug; 34(8):1515-8. PubMed ID: 3195413
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of ofloxacin against complicated urinary tract infections].
Nishio S; Yoshihara H
Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217
[TBL] [Abstract][Full Text] [Related]
36. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
Kawamura J; Hayashi N; Okabe S; Kawahara S; Chigusa I; Araki T; Saito K; Takeno K; Suzuki N; Suzuki I
Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
Suzuki K; Nagata Y
Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
[TBL] [Abstract][Full Text] [Related]
38. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
Peters HJ; Eicher R
MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of Claforan (CTX) in aged patients with chronic complicated urinary tract infections].
Washida H; Tsugaya M; Hirao N; Hachisuka Y
Hinyokika Kiyo; 1984 Jan; 30(1):121-9. PubMed ID: 6328960
[TBL] [Abstract][Full Text] [Related]
40. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
